CONFERENCES

      International Mass Spectrometry Conference

      IMSC is a biennial conference that focuses on the latest developments in mass spectrometry and related technologies, with topics ranging from drug discovery to environmental analysis. The conference is aimed at researchers, instrument manufacturers, and other professionals involved in the use and development of mass spectrometry, and provides a forum for sharing knowledge and collaborating on new approaches to analysis.

      IMSC Conference 2018

      Date

      Aug 26, 2018 - Aug 31, 2018

      Location

      Florence, Italy

      As all the previous editions, IMSC 2018 will cover all aspects of mass spectrometry, from fundamentals to instrumentation and applications. The conference is organized with short courses, oral and poster sessions, workshops, awards, commercial exhibition, social program, and companies user meetings.

      IMSC Conference 2016

      Date

      Aug 20, 2016 - Aug 26, 2016

      Location

      Toronto, Canada

      21st International Mass Spectrometry Conference includes talks and presentations on improving mass spectrometry education, the standardization of the terminology used in the field, and the latest technological advances.

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.